HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoto Imoto Selected Research

B cell linker protein

2/2016B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoto Imoto Research Topics

Disease

4Neoplasms (Cancer)
01/2019 - 08/2016
2Lymphoma (Lymphomas)
05/2022 - 02/2021
2Leukemia
01/2019 - 02/2016
2Philadelphia Chromosome
08/2016 - 01/2016
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2016 - 02/2016
1Communicable Diseases (Infectious Diseases)
12/2021
1Pneumonia (Pneumonitis)
12/2021
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
12/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
12/2021
1Toxoplasmosis
12/2021
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2021
1Hairy Cell Leukemia
02/2021
1Hypoprothrombinemias (Prothrombin Deficiency)
01/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020
1Genetic Translocation (Chromosomal Translocation)
01/2019
1Disease Progression
10/2017
1Pulmonary Hemosiderosis
10/2017
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2017
1Ascites
06/2017
1Primary Effusion Lymphoma
06/2017
1Hematologic Neoplasms (Hematological Malignancy)
01/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017
1Hemorrhage
01/2017
1Pulmonary Alveolar Proteinosis
01/2017
1B-Cell Leukemia (Leukemia, B Cell)
01/2016

Drug/Important Bio-Agent (IBA)

2Rituximab (Mabthera)FDA Link
05/2022 - 02/2021
2Proteins (Proteins, Gene)FDA Link
01/2019 - 02/2016
1Methotrexate (Mexate)FDA LinkGeneric
05/2022
1Procarbazine (Matulane)FDA Link
05/2022
1Vincristine (Oncovin)FDA LinkGeneric
05/2022
1Thomsen-Friedenreich antibodiesIBA
12/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021
1Anti-Bacterial Agents (Antibiotics)IBA
12/2021
1Inosine Triphosphate (ITP)IBA
12/2021
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
12/2021
1Bendamustine HydrochlorideFDA Link
02/2021
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2019
1IronIBA
10/2017
1sepantroniumIBA
06/2017
1Proteasome Endopeptidase Complex (Proteasome)IBA
06/2017
1AutoantibodiesIBA
01/2017
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2017
1Verteporfin (Visudyne)FDA Link
08/2016
1Dasatinib (BMS 354825)FDA Link
08/2016
1Photosensitizing Agents (Photosensitizers)IBA
08/2016
1Pharmaceutical PreparationsIBA
08/2016
1B cell linker proteinIBA
02/2016
1RNA (Ribonucleic Acid)IBA
01/2016

Therapy/Procedure

2Drug Therapy (Chemotherapy)
10/2017 - 01/2017
1Radiotherapy
05/2022
1Therapeutics
12/2021
1Hematopoietic Stem Cell Transplantation
12/2021
1Remission Induction
01/2017
1Transplantation
01/2016